Alpha Tau Medical Ltd ( DRTS) - Key Metrics
DRTS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.50 | $0 | $0 |
| 2026Q1 | $0 | -$0.26 | $0 | $0 |
| 2025Q4 | $0 | -$0.14 | -$0.31 | -$0.38 |
| 2025Q3 | $0 | -$0.14 | $0 | $0 |
| 2025Q2 | $0 | -$0.13 | $0 | $0 |
DRTS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.29 |
| 2026Q1 | 0% | -6.80 |
| 2025Q4 | 0% | -8.84 |
| 2025Q3 | 0% | -8.05 |
| 2025Q2 | 0% | -6 |
DRTS
Price: $14.43
52 week price:
Earnings Per Share: -1.04 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.3 billion